SI-3

1-(2,6-Diisopropylphenyl)-3-(4-(hydroxymethyl)benzyl)-1H-imidazol-3-ium chloride (7b):
3-(4-(Chloromethyl)benzyl)-1-mesityl-1H-imidazol-3-ium chloride (8a):
Compound 7a (2.11 g, 6.15 mmol) was dissolved in CHCl 3 (60 mL) and pyridine (25 μL, 0.31 mmol) thionyl chloride (1.11 mL, 15.3 mmol) were added. The solution was stirred at rt for 30 min. Aqueous NaHCO 3 was added and the phases were separated. The aqueous phase was extracted with CHCl 3 and the combined organic phases were washed with aqueous NaCl, dried with MgSO 4 and filtrated. The solvent was evaporated in vacuo. Then CH 2 Cl 2 (10 mL) was added, followed by Et 2 O. The resulting precipitate was filtrated, washed with Et 2 O and dried in vacuo to give 8a (2.14 g, 5.92 mmol, 96%) as a yellow solid. MP: 93. 
3-(4-(Chloromethyl)benzyl)-1-(2,6-diisopropylphenyl)-1H-imidazol-3-ium chloride (8b):
Compound 8b synthesized according to the procedure of 8a. 7b (1.14 g, 2.97 mmol) was dissolved in CHCl 3 (30 mL), then pyridine (12 μL, 0.15 mmol) and thionyl chloride (538 μL, 7.42 mmol) were added to give 8b (1.08 g, 2.68 mmol, 90%) as yellow powder. MP: 89.6 °C; 1 H NMR (500 MHz, CDCl 3 ) δ 10.80 (s, 1H), 8.07 (s, 1H), 7.67 (d, J = 8.1 Hz, 2H), 7.48 (t, J = 7.9 Hz, 1H), 7.34 (d, J = 8.1 Hz, 2H), 7.24 (d, J = 7.9 Hz, 2H), 7.11 (s, 1H), 6.00 (s, 2H), 4.53 (s, 2H), 2.19 (spt, J = 6.8 Hz, 2H), 1.15 (d, J = 6.9 Hz, 6H), 1.08 (d, J = 6.7 Hz, 6H); 
3-(4-((Triethylammonium)methyl)benzyl)-1-mesityl-1H-imidazol-3-ium chloride (9ab):
Compound 9ab was synthesized according to the procedure of 9aa. 8a (400 mg, 
3-(4-((Tributylammonium)methyl)benzyl)-1-mesityl-1H-imidazol-3-ium chloride (9ac):
Compound 9ac was synthesized according to the procedure of 9aa. 8a (400 mg, 1.107 mmol) was dissolved in MeOH (15 mL) and Bu 3 N (5 mL, 21.035 mmol) was added to give 9ac (400 mg, 0.7317 mmol, 66%) as brownish powder. 
(1-(4-((Tributylammonio)methyl)benzyl)-3-mesityl-2,3-dihydro-1H-imidazol-2-yl)gold(I) chloride (1ac):
According to the synthesis of 1aa, 9ac (93 mg, 0.170 mmol) was dissolved in MeOH (5 mL) and KOtBu (19 mg, 0.169 mmol) and Au(SMe 2 )Cl (50 mg, 0.169 mmol) were added. 1ac (90 mg, 0.121 mmol, 71%) was obtained as an off-white powder. 
SI-7 (1-(2,6-Diisopropylphenyl)-3-(4-((trimethylammonio)methyl)benzyl)-2,3-dihydro-1H-imidazol-2-yl)gold(I) chloride (1ba):
According to the synthesis of 1aa, 9ba (112 mg, 0.242 mmol) was dissolved in MeOH (5 mL) and KOtBu (27 mg, 0.241 mmol) and Au(SMe 2 )Cl (71 mg, 0.241 mmol) were added. 1ba (120 mg, 0.182 mmol, 75%) was obtained as an off-white powder. 
(1-(2,6-Diisopropylphenyl)-3-(4-((tributylammonio)methyl)benzyl)-2,3-dihydro-1H-imidazol-2-yl)gold(I) chloride (1bc):
According to the synthesis of 1aa, 9bc (100 mg, 0.170 mmol) was dissolved in MeOH (5 mL) and KOtBu (19 mg, 0.169 mmol) and Au(SMe 2 )Cl (50 mg, 0.169 mmol) were added. 1bc (107 mg, 0.136 mmol, 80%) was obtained as an off-white powder. . The methyl ester of 10e was synthesized according to reference 5 and the ester was cleaved with NaOH according to reference 3 .
General procedure for the cycloisomerization of alkynoic acids Alkynoic acid 10 (40 mg) was dissolved in 1M Et 3 N·HOAc buffer solution (2mL) under air. Carboxylic acids which are not soluble in water were dissolved in THF first to give a 0.5 M solution. Then catalyst 1a/1b (2.5 mol%) was added. The reaction was monitored by TLC. After full conversion, the solution was extracted with Et 2 O (5x2 mL). The combined organic phases were dried over MgSO 4 , filtered and the solvent was removed in vacuo. Purification by column chromatography gave γ-alkylidene lactone 11. The recycling was performed by addition of fresh alkynoic acid to the aqueous phase and repetition of the procedure.
5-Methylenedihydrofuran-2-one (11a):
Colorless oil. 
4-Oxopentanoic acid (12a):
12a was synthesized according to the general procedure for the cycloisomerization of alkynoic acids. As starting material 11a was used. Colorless oil. 
Gold-catalyzed Cyclization of Amides
General procedure for the cycloisomerization of alkynoic amides A solution of 0.3 M amide 13 (40 mg) in THF was added to 1M Et 3 N·HOAc buffer solution (2mL) under air. Then catalyst 1a/1b (2.5 mol%) was added. The reaction was monitored by TLC. After full conversion, the solution was extracted with Et 2 O (5x2 mL). The combined organic phases were dried over MgSO 4 , filtered and the solvent was removed in vacuo. Purification by column chromatography gave γ-alkylidene lactam 14. The recycling was performed by addition of fresh amide to the aqueous phase and repetition of the procedure. 
5-
3-Isopropyl-5-methylene-1-tosylpyrrolidin-2-one (14c):
Yellowish oil. 
5-Methylene-3-phenyl-1-tosylpyrrolidin-2-one (14d):
Yellow oil. 1 H NMR (500MHz ,CDCl 3 ) δ = 7.96 (d, J = 8.0 Hz, 2H), 7.34 (d, J = 8.0 Hz, 2H), 7.31-7.24 (m, 3H), 7.10 (dd, J = 1.5, 7.6 Hz, 2H), 5.60 (d, J = 1.5 Hz, 1H), 4.68 (d, J = 1.5 Hz, 1H), 3.72 (dd, J = 7.5, 9.8 Hz, 1H), 3.12 (tdd, J = 1.5, 9.6, 15.7 Hz, 1H), 2.84 (tdd, J = 1.8, 7.3, 15.6 Hz, 1H), 2.45 (s, 3H); 13 
Synthesis of 2-epi-Clausemarine A (16) (S)-tert-Butyldimethyl((2-methylpent-4-in-1-yl)oxy)silane (S2)
OH
S1
10,11,12 (13.4 g, 35.8 mmol) was dissolved in THF (90 mL) and a solution of NaBH 4 (6.77 g, 179.0 mmol) in water (50 mL) was added dropwise. The mixture was stirred overnight at rt and then hydrolyzed with aqueous NH 4 Cl and water. The solvent was removed in vacuo and the precipitate was filtrated and washed with a small amount of MeOH to give the Evans auxiliary as a brownish solid which can be purified by recrystallization with MeOH. The filtrate was extracted with Et 2 O several times and the combined organic phases were dried with MgSO 4 , filtrated and the solvent was removed under reduced pressure (max. down to 200 mbar) to give the (S)-2-methylpent-4-in-1-ol which was converted without further purification. The alcohol was dissolved in dry DMF (30 mL) under an Ar atmosphere and imidazole (4.60 g, 67.6 mmol) and tert-Butyldimethylsilyl chloride (4.27 g, 28.3 mmol) were added at 0 °C. After 2 h at rt water was added and the phases were separated. The aqueous phase was extracted with Et 2 O several times, dried with MgSO 4 , filtrated and the solvent was removed in vacuo. After purification by column chromatography (SiO 2 , cyclohexane/EtOAc, 5:1) S2 (4.82 g, 22.7 mmol, 63% over 2 steps) was given as colorless oil. 1 H NMR (500MHz, CDCl 3 ) δ = 3.52 (dd, J = 5.7, 9.9 Hz, 1H), 3.48 (dd, J = 6.5, 9.6 Hz, 1H), 2.30 (ddd, J = 2.7, 6.1, 16.8 Hz, 1H), 2.13 (ddd, J = 2.7, 6.9, 16.8 Hz, 1H), 1.94 (t, J = 2.7 Hz, 1H), 1.85 (qd, J = 6.3, 12.8 Hz, 1H), 0.98 (d, J = 6.9 Hz, 3H), 0.90 (s, 9H), 0.06 (s, 6H); 13 C NMR (125MHz, CDCl 3 ) δ = 83.3, 69.2, 66.9, 35.3, 27.1, 26.1, 22.2, 18.5, 16.1, -5.2, -5.3. Known compound.
SI-13 (6S)-7-((tert-Butyldimethylsilyl)oxy)-6-methylhept-3-yn-2-ol (S3):
Under an Ar atmosphere, alkyne S2 (1.80 g, 8.47 mmol) was dissolved in dry THF (10 mL). At -78°C nBuLi (4.40 mL, 10.2 mmol, 2.5M in hexane) was added and the solution was stirred for 30 min. Then acetaldehyde (0.72 mL, 12.7 mmol) was added and the solution was warmed up to 0 °C during 1 h. Then aqueous NH 4 Cl and Et 2 O were added and the phases were separated. The aqueous phase was extracted with Et 2 O several times and the combined organic phases were dried with MgSO 4 , filtrated and the solvent was evaporated in vacuo. After purification by column chromatography (SiO 2 , cyclohexane/EtOAc, 2:1) S3 (1.69 g, 6.60 mmol, 78%) was isolated as colorless oil. S3 (1.13 g, 4.41 mmol) was dissolved in DCM (110 mL) under an Ar atmosphere and Ac 2 O (0.87 mL, 9.25 mmol), Et 3 N (1.28 mL, 9.25 mmol) and DMAP (108 mg, 0.88 mmol) were added at rt. After 3 h the reaction was hydrolyzed with diluted HCl. The organic phase was washed with aqueous NaHCO 3 and the aqueous phase was extracted with DCM several times. The combined organic phases were dried with MgSO 4 , filtrated and the solvent was removed in vacuo. The product was identified as colorless oil, which was converted without further purification. Under Ar atmosphere the silyl ether was dissolved in dry THF (15 mL) and TBAF (4.86 mL, 4.86 mmol, 1M in THF) was added at 0 °C. After 3 h at rt THF was removed in vacuo. After purification by column chromatography (SiO 2 , cyclohexane/EtOAc, 10:1, 7:1) S4 (716 mg, 3.88 mmol, 88% over 2 steps) was given as colorless oil. S4 (745 mg, 4.04 mmol) was dissolved in dry DMSO (15 mL) under an Ar atmosphere and IBX (3.40 g, 12.13 mmol) was added. After 3 h at rt the solution was added to an ice/water bath and the precipitate was removed by filtration. The filtrate was extracted with Et 2 O several times. The combined organic phases were dried with MgSO 4 , filtrated and the solvent was removed in vacuo. The product was given as colorless oil and was converted without further purification. The aldehyde was dissolved in 2-methyl-2-butene (3.66 mL, 34.4 mmol) and tBuOH (90 mL) and then a solution of NaClO 2 (3.51 g, 38.8 mmol) and NaH 2 PO 4 (3.53 g, 29.4 mmol) in water (25 mL) was added. After 1 h at rt a pH value of 8 was adjusted by addition of diluted NaOH and tBuOH was removed in vacuo. Then water and brine were added and the solution was extracted with cyclohexane once. Then the pH value was adjusted at 3 by addition of diluted HCl and the aqueous phase was extracted with EtOAc several times. 
(3S,5S)-3-Methyl-5-(2-oxopropyl)dihydrofuran-2-one (19):
O O O 18 (440 mg, 2.81 mmol) was dissolved in dry MeOH (10 mL) under H 2 atmosphere and Pd/C (300 mg) was added. The solution was stirred overnight at rt and the catalyst was removed by filtration over celite. The solvent was evaporated in vacuo and the product was converted without further purification. The alcohol was dissolved in dry DMSO (10 mL) under an Ar atmosphere and IBX (2.36 g, 8.43 mmol) was added. The solution was stirred overnight and then poured into iced water. The precipitate was removed by filtration and the filtrate was extracted with Et 2 O several times. The combined organic phases were dried with MgSO 4 , filtrated and the solvent was removed in vacuo. After purification by column chromatography (SiO 2 , cyclohexane/EtOAc, 1:1), 19 (180 mg, 1.15 mmol, 41% over 2 steps) was given as yellowish oil. 1 H NMR (500MHz, C 6 D 6 ) δ = 4.19 (ddd, J = 5.4, 10.7, 11.9 Hz, 1H), 2.21 (dd, J = 6.5, 16.8 Hz, 1H), 1.96-1.86 (m, 1H), 1.83-1.78 (m, 1H), 1.75 (dd, J = 6.1, 17.2 Hz, 1H), 1.57 (s, 3H), 0.95 (d, J = 6.9 Hz, 3H), 0.75 (dt, J = 10.5, 12.1 Hz, 1H); 13 19 (120 mg, 0.768 mmol) was dissolved in dry THF (1 mL) under an Ar atmosphere and vinylmagnesium bromide (1.65 mL, 1.15 mmol, 0.7M in THF) was added. The turbid solution was hydrolyzed after 30 min by addition of aqueous NH 4 Cl, the phases were separated and the aqueous phase was extracted with EtOAc several times. The combined organic phases were dried with MgSO 4 , filtrated and the solvent was removed in vacuo. The product was converted without further purification. The tertiary alcohol was dissolved in dry Et 2 O (3 mL) and PBr 3 (130 μL, 1.38 mmol) was added at 0 °C. After 30 min Et 2 O was added and the solution was hydrolyzed by addition of aqueous NaHCO 3 . The phases were separated and the organic phase was washed with brine, dried with MgSO 4 , filtrated and the solvent was removed in vacuo. After purification by column chromatography (SiO 2 , cyclohexane/EtOAc, 3:1), 20 (58 mg,
